跳至主要内容
临床试验/CTRI/2022/02/039967
CTRI/2022/02/039967尚未招募2 期

A comparative clinical study of Virechana Karmaand Drakshadi churna along with Matra Basti inthe management of Asrigdara w.s.r. to AbnormalUterine Bleeding

ational institute of Ayurveda Jaipur Rajasthan0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients complaining of Asrigdara having any two of
  • the following symptoms:
  • Heavy menstrual bleeding.
  • Prolonged menstrual bleeding.
  • Inter menstrual bleeding.
  • 2.Hb level equal or more than 8 gm/dl
  • 3.Age between 12 year to 50 years

排除标准

  • 1. Pregnant woman
  • 2. Patients having bleeding due to abortion.
  • 3. Ectopic Pregnancy.
  • 4. Patients having any systemic diseases.
  • 5. Patients having coagulation disorders.
  • 6. Patients having bleeding after menopause.
  • 7. Any type of malignancy.
  • 8. Patients having STDs.
  • 9. Patients using IUCDs.
  • 10.Thyroid hormones abnormalities
  • 11.Uterine and pelvic pathology like -Polyps,
  • Endometrial T.B, Fibroid, Adenomyosis, PID etc.

研究者

发起方
ational institute of Ayurveda Jaipur Rajasthan

相似试验